AstraZeneca PLC (AZN) — Financial statements
Income statement, balance sheet, and cash flow for AstraZeneca PLC — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 58,739↑8.6% | 54,073↑18.0% | 45,811↑3.3% | 44,351↑18.5% | 37,417 | |
| Cost of Revenue | 10,633↑4.2% | 10,207↑23.5% | 8,268↓33.3% | 12,391↓0.4% | 12,437 | |
| Gross Profit | 48,106↑9.7% | 43,866↑16.8% | 37,543↑17.5% | 31,960↑27.9% | 24,980 | |
| Operating Expenses | ||||||
| R&D Expenses | 14,232↑4.8% | 13,583↑24.2% | 10,935↑12.0% | 9,762↑0.3% | 9,736 | |
| General & Administrative Expenses | 19,933↑1.3% | 19,669↑11.2% | 17,683↑1.3% | 17,448↑15.2% | 15,144 | |
| Selling & Marketing Expenses | 579↑4.3% | 555↑3.0% | 539↑0.6% | 536↑20.2% | 446 | |
| SG&A Expenses | 20,512↑1.4% | 20,224↑11.0% | 18,222↑1.3% | 17,984↑15.4% | 15,590 | |
| Other Expenses | -381↓780.4% | 56↓71.0% | 193↓57.8% | 457↑132.6% | -1,402 | |
| Operating Expenses | 34,363↑1.5% | 33,863↑15.4% | 29,350↑4.1% | 28,203↑17.9% | 23,924 | |
| Total Costs & Expenses | 44,996↑2.1% | 44,070↑17.2% | 37,618↓7.3% | 40,594↑11.6% | 36,361 | |
| Operating Results | ||||||
| Operating Income | 13,743↑37.4% | 10,003↑22.1% | 8,193↑118.1% | 3,757↑255.8% | 1,056 | |
| Depreciation & Amortization | 5,733↑13.2% | 5,065↑2.7% | 4,934↓6.1% | 5,254↑28.1% | 4,102 | |
| EBITDA | 19,829↑28.4% | 15,438↑15.0% | 13,422↑47.7% | 9,085↑77.7% | 5,113 | |
| EBIT | 14,096↑35.9% | 10,373↑22.2% | 8,488↑121.6% | 3,831↑278.9% | 1,011 | |
| Interest & Other Income | ||||||
| Net Interest Income | -1,334↑0.2% | -1,337↓3.8% | -1,288↓3.1% | -1,249↓1.3% | -1,233 | |
| Interest Income | 360↑4.3% | 345↑14.6% | 301↑271.6% | 81↑88.4% | 43 | |
| Interest Expense | 1,694↑0.7% | 1,682↑5.9% | 1,589↑19.5% | 1,330↑4.2% | 1,276 | |
| Non-Operating Income | -353↑4.6% | -370↓25.4% | -295↓298.6% | -74↓264.4% | 45 | |
| Other Income / Expenses | -1,341↓2.2% | -1,312↓1.4% | -1,294↓3.0% | -1,256↑4.9% | -1,321 | |
| Income Before Tax | 12,402↑42.7% | 8,691↑26.0% | 6,899↑175.8% | 2,501↑1043.8% | -265 | |
| Income Tax Expense | 2,169↑31.5% | 1,650↑75.9% | 938↑218.4% | -792↓108.4% | -380 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 10,233↑45.3% | 7,041↑18.1% | 5,961↑81.0% | 3,293↑2763.5% | 115 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 10,255↑45.8% | 7,035↑18.1% | 5,955↑81.1% | 3,288↑2835.7% | 112 | |
| Bottom-Line Net Income | 10,255↑45.8% | 7,035↑18.1% | 5,955↑81.1% | 3,288↑2835.7% | 112 | |
| EPS (Basic) | 6.60↑190.7% | 2.27↓40.4% | 3.81↑79.7% | 2.12↑2550.0% | 0.08 | |
| EPS (Diluted) | 6.54↑190.7% | 2.25↓40.9% | 3.81↑80.6% | 2.11↑2537.5% | 0.08 | |
| Weighted Average Shares | 1,550↑0.0% | 1,550↓0.8% | 1,562↑0.9% | 1,548↑9.2% | 1,418 | |
| Weighted Average Diluted Shares | 1,562↓0.1% | 1,563↑0.1% | 1,562↑0.1% | 1,560↑9.3% | 1,427 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.